AllianceBernstein’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-82,600
Closed -$350K 3553
2021
Q1
$350K Hold
82,600
﹤0.01% 2839
2020
Q4
$320K Hold
82,600
﹤0.01% 2827
2020
Q3
$333K Hold
82,600
﹤0.01% 2761
2020
Q2
$352K Buy
82,600
+3,200
+4% +$19.5K ﹤0.01% 2812
2020
Q1
$333K Hold
79,400
﹤0.01% 2566
2019
Q4
$312K Hold
79,400
﹤0.01% 2761
2019
Q3
$699K Sell
79,400
-3,400
-4% -$32.1K ﹤0.01% 2407
2019
Q2
$766K Buy
82,800
+50,300
+155% +$379K ﹤0.01% 2427
2019
Q1
$209K Sell
32,500
-81,948
-72% -$534K ﹤0.01% 2895
2018
Q4
$1.08M Buy
114,448
+92,148
+413% +$1.39M ﹤0.01% 2160
2018
Q3
$449K Sell
22,300
-1,900
-8% -$49.7K ﹤0.01% 2669
2018
Q2
$706K Sell
24,200
-87,900
-78% -$2.71M ﹤0.01% 2473
2018
Q1
$3.34M Buy
112,100
+95,000
+556% +$3.06M ﹤0.01% 1469
2017
Q4
$550K Sell
17,100
-17,000
-50% -$556K ﹤0.01% 2503
2017
Q3
$1.19M Buy
34,100
+17,000
+99% +$547K ﹤0.01% 2191
2017
Q2
$509K Buy
17,100
+4,400
+35% +$126K ﹤0.01% 2608
2017
Q1
$379K Hold
12,700
﹤0.01% 2619
2016
Q4
$223K Hold
12,700
﹤0.01% 2857
2016
Q3
$302K Hold
12,700
﹤0.01% 2693
2016
Q2
$203K Buy
+12,700
New +$228K ﹤0.01% 2800
2016
Q1
Sell
-7,600
Closed -$205K 2998
2015
Q4
$205K Buy
+7,600
New +$207K ﹤0.01% 2743

Other funds holding LJPC

AllianceBernstein's LJPC Position: Q2 2021 in Review

AllianceBernstein sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 82,600 shares — an estimated $350K sold.

AllianceBernstein first reported a position in LJPC in Q4 2015 and held it in 21 quarters. The position peaked at $3.34M in Q1 2018. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • AllianceBernstein reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • AllianceBernstein sold 82,600 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $350K.
  • AllianceBernstein first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 21 quarters.
  • AllianceBernstein's La Jolla Pharmaceutical Company position peaked at $3.34M in Q1 2018.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.